First survey for detecting the presence of human herpesvirus 8 infection (HHV-8) in Maputo, Mozambique.

Human herpesvirus 8 (HHV-8), the etiological agent of Kaposi's sarcoma (KS), is endemic in parts of the sub-Saharan, and KS has increased concomitantly with the HIV/AIDS epidemic. In Mozambique (MZ), no data concerning HHV-8 infection was available, thus the main of this work was to investigate, for the first time, the presence of HHV-8 infection in Maputo, MZ. Latent and lytic HHV-8-specific antibodies were assessed in blood samples from 189 individuals from the Central Hospital of Maputo, MZ, using 'in-house' immunofluorescence assays conducted in São Paulo, Brazil. The results obtained were analyzed according to socio-demographic and clinical variables using the Chi-square test and logistic regression. An HHV-8 seropositivity of 1.8% and 9.7% was detected among 57 medical students and 31 individuals from the staff, respectively, in contrast to 16.4% detected among 67 out-patients. Concerning 34 hospitalized patients from the Dermatology Unit, 47.1% were HHV-8-seropositive overall, while the rate was 85.7% among KS patients. The present survey, conducted in Maputo, MZ, demonstrates great variation in HHV-8 infection frequencies depending on the group analyzed and epidemiological variables. An association between HHV-8 seropositivity and male gender (OR 5.72), the central origin of patients (OR 5.33), blood transfusions (OR 3.25), and KS (OR 24.0) was detected among hospitalized patients, and primary school (OR 7.18) and HIV-1 infection (OR 8.76) among out-patients.

[1]  J. Jabłecki,et al.  Kaposi's sarcoma revisited. , 2007, AIDS reviews.

[2]  A. Caterino-de-Araujo Opinion - The fight against Kaposi's sarcoma in AIDS - lessons from Brazil , 2007 .

[3]  A. Caterino-de-Araujo The fight against Kaposis sarcoma in AIDS -- lessons from Brazil. , 2007 .

[4]  Fabrício Jacob,et al.  Otimização e avaliação do ensaio de imunofluorescência indireta para pesquisa de anticorpos anti-herpesvírus humano 8 (HHV-8) usando sangue colhido em papel de filtro , 2007 .

[5]  P. Mayaud,et al.  AIDS‐related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub‐Saharan Africa , 2005, Tropical medicine & international health : TM & IH.

[6]  J. Goedert,et al.  Water, Socioeconomic Factors, and Human Herpesvirus 8 Infection in Ugandan Children and Their Mothers , 2005, Journal of acquired immune deficiency syndromes.

[7]  A. Caterino-de-Araujo,et al.  Confirming Shedding of Human Herpesvirus 8 in Urine from Infected Patients in Brazil , 2005, Journal of Clinical Microbiology.

[8]  U. Lalloo,et al.  Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8. , 2005, The Journal of infectious diseases.

[9]  T. Flanigan,et al.  The extraordinary hope of antiretroviral therapy in South Africa (even for patients with tuberculosis or kaposi sarcoma!). , 2005, The Journal of infectious diseases.

[10]  P. Ruff,et al.  Low socioeconomic status and risk for infection with Human Herpesvirus 8 among HIV-1 negative, South African black cancer patients , 2004, Epidemiology and Infection.

[11]  R. Newton,et al.  Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma , 2003, British Journal of Cancer.

[12]  Thomas Ruzicka,et al.  Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. , 2002, The Lancet. Infectious diseases.

[13]  A. Caterino-de-Araujo,et al.  Absence of an association between the presence of human herpesvirus 8 antibodies and the development of Kaposi's sarcoma in HIV-1-infected patients receiving antiretroviral therapy. , 2000, AIDS.